DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Database

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
1–13 of 13 · LongevityClear filters
  1. 001

    Epithalon (Epitalon)

    A synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed from the amino acid composition of epithalamin, a peptide extract of the pineal gland. In cell culture…

    Longevity · Investigational · Subcutaneous injection, Intravenous

    No lawful pathway
  2. 002

    MOTS-c

    A 16-amino acid mitochondrial-derived peptide encoded by a short open reading frame in the 12S rRNA gene of mitochondrial DNA. In mice and cells, MOTS-c…

    Longevity · Research Phase · Subcutaneous injection

    No lawful pathway
  3. 003

    Humanin

    A 24-amino acid mitochondrial-derived peptide whose coding sequence is nearly identical to a region of the mitochondrial 16S rRNA gene. Humanin acts as a…

    Longevity · Research Phase · Subcutaneous injection, Intravenous

    No lawful pathway
  4. 004

    NAD+ Precursors (NMN)

    Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular metabolism…

    Longevity · In Clinical Trials · Oral, Intravenous, Sublingual

    No lawful pathway
  5. 005

    SS-31 (Elamipretide)

    A mitochondria-targeted tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that selectively binds cardiolipin in the inner mitochondrial membrane. In laboratory…

    Longevity · FDA Approved · Subcutaneous injection, Intravenous

    FDA-approved
  6. 006

    FOXO4-DRI

    A D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells. FOXO4 helps senescent cells avoid apoptosis by binding…

    Longevity · Research Phase · Subcutaneous injection, Intravenous

    No lawful pathway
  7. 007

    Gonadotropin Releasing Hormone (GnRH) Agonists

    Gonadotropin-releasing hormone agonists are synthetic analogues of native GnRH that initially stimulate and then, with continuous exposure, downregulate…

    Longevity · FDA Approved · Subcutaneous injection, Intramuscular injection, Subcutaneous implant, Intranasal

    FDA-approved
  8. 008

    Klotho Peptide

    Klotho is a protein that exists in membrane-bound and secreted forms, with the soluble ectodomain acting as a circulating factor. It serves as a coreceptor for…

    Longevity · Research Phase · Intravenous

    No lawful pathway
  9. 009

    Sirtuin-Activating Peptides

    Sirtuin-activating peptides are a proposed class of compounds intended to enhance the activity of sirtuins, a family of NAD-dependent deacetylases implicated…

    Longevity · Research Phase · Subcutaneous injection

    No lawful pathway
  10. 010

    Mitochondrial-Targeted Peptides (MTP)

    Mitochondrial-targeted peptides are short synthetic sequences designed to localize to mitochondria and limit oxidative damage and organelle dysfunction. The…

    Longevity · FDA Approved · Subcutaneous injection, Intravenous

    FDA-approved
  11. 011

    Gerontin (Pineal Gland Extract)

    Gerontin is a name applied to peptide fractions derived from pineal gland extracts in Russian gerontology research. No publications indexed in PubMed under…

    Longevity · Research Phase · Subcutaneous injection

    No lawful pathway
  12. 012

    Vilon (Lys-Glu)

    Vilon is a synthetic dipeptide consisting of lysine and glutamic acid (Lys-Glu) developed as part of the Khavinson bioregulator peptide research program. The…

    Longevity · Investigational · Subcutaneous injection, Oral

    No lawful pathway
  13. 013

    Bioregulator Peptides (Khavinson)

    Bioregulator peptides are a class of short synthetic peptides, typically 2 to 4 amino acids in length, developed by Russian researcher Vladimir Khavinson based…

    Longevity · Investigational · Subcutaneous injection, Oral, Intramuscular injection

    No lawful pathway

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.